New pharmaceuticals in inflammatory bowel disease

This paper complements the previously published Guidelines of the Working Group of the Polish Society of Gastroenterology and former National Consultant in Gastroenterology regarding the management of patients with Crohn's disease and ulcerative colitis. Attention was focused on the new pharmac...

Descripción completa

Detalles Bibliográficos
Autores principales: Łodyga, Michał, Eder, Piotr, Bartnik, Witold, Gonciarz, Maciej, Kłopocka, Maria, Linke, Krzysztof, Małecka-Panas, Ewa, Radwan, Piotr, Rydzewska, Grażyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2015
Materias:
Special Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631272/
https://www.ncbi.nlm.nih.gov/pubmed/26557934
http://dx.doi.org/10.5114/pg.2015.52702
_version_ 1782398832864133120
author Łodyga, Michał
Eder, Piotr
Bartnik, Witold
Gonciarz, Maciej
Kłopocka, Maria
Linke, Krzysztof
Małecka-Panas, Ewa
Radwan, Piotr
Rydzewska, Grażyna
author_facet Łodyga, Michał
Eder, Piotr
Bartnik, Witold
Gonciarz, Maciej
Kłopocka, Maria
Linke, Krzysztof
Małecka-Panas, Ewa
Radwan, Piotr
Rydzewska, Grażyna
author_sort Łodyga, Michał
collection PubMed
description This paper complements the previously published Guidelines of the Working Group of the Polish Society of Gastroenterology and former National Consultant in Gastroenterology regarding the management of patients with Crohn's disease and ulcerative colitis. Attention was focused on the new pharmaceutical recently registered for inflammatory bowel disease treatment.
format Online
Article
Text
id pubmed-4631272
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-46312722015-11-10 New pharmaceuticals in inflammatory bowel disease Łodyga, Michał Eder, Piotr Bartnik, Witold Gonciarz, Maciej Kłopocka, Maria Linke, Krzysztof Małecka-Panas, Ewa Radwan, Piotr Rydzewska, Grażyna Prz Gastroenterol Special Paper This paper complements the previously published Guidelines of the Working Group of the Polish Society of Gastroenterology and former National Consultant in Gastroenterology regarding the management of patients with Crohn's disease and ulcerative colitis. Attention was focused on the new pharmaceutical recently registered for inflammatory bowel disease treatment. Termedia Publishing House 2015-07-01 2015 /pmc/articles/PMC4631272/ /pubmed/26557934 http://dx.doi.org/10.5114/pg.2015.52702 Text en Copyright © 2015 Termedia http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Special Paper
Łodyga, Michał
Eder, Piotr
Bartnik, Witold
Gonciarz, Maciej
Kłopocka, Maria
Linke, Krzysztof
Małecka-Panas, Ewa
Radwan, Piotr
Rydzewska, Grażyna
New pharmaceuticals in inflammatory bowel disease
title New pharmaceuticals in inflammatory bowel disease
title_full New pharmaceuticals in inflammatory bowel disease
title_fullStr New pharmaceuticals in inflammatory bowel disease
title_full_unstemmed New pharmaceuticals in inflammatory bowel disease
title_short New pharmaceuticals in inflammatory bowel disease
title_sort new pharmaceuticals in inflammatory bowel disease
topic Special Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631272/
https://www.ncbi.nlm.nih.gov/pubmed/26557934
http://dx.doi.org/10.5114/pg.2015.52702
work_keys_str_mv AT łodygamichał newpharmaceuticalsininflammatoryboweldisease
AT ederpiotr newpharmaceuticalsininflammatoryboweldisease
AT bartnikwitold newpharmaceuticalsininflammatoryboweldisease
AT gonciarzmaciej newpharmaceuticalsininflammatoryboweldisease
AT kłopockamaria newpharmaceuticalsininflammatoryboweldisease
AT linkekrzysztof newpharmaceuticalsininflammatoryboweldisease
AT małeckapanasewa newpharmaceuticalsininflammatoryboweldisease
AT radwanpiotr newpharmaceuticalsininflammatoryboweldisease
AT rydzewskagrazyna newpharmaceuticalsininflammatoryboweldisease

Ejemplares similares